Since the inception of the model for end-stage liver disease (MELD) liver transplant allocation system in 2002, it has been recognized that some diseases exist for which mortality risk is not adequately measured by MELD score. For this reason patients with hepatocellular carcinoma (HCC) have been assigned an exception MELD score. In this issue of AJT (1)
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